| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-11 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-09 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-09 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
1e-08 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-08 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-08 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-08 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
1e-07 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |